Literature DB >> 16324761

Clonal derivation and characterization of human embryonic stem cell lines.

Nico Heins1, Anders Lindahl, Ulrika Karlsson, Marie Rehnström, Gunilla Caisander, Katarina Emanuelsson, Charles Hanson, Henrik Semb, Petter Björquist, Peter Sartipy, Johan Hyllner.   

Abstract

Human embryonic stem cells (hESC) are isolated as clusters of cells from the inner cell mass of blastocysts and thus should formally be considered as heterogeneous cell populations. Homogenous hESC cultures can be obtained through subcloning. Here, we report the clonal derivation and characterization of two new hESC lines from the parental cell line SA002 and the previously clonally derived cell line AS034.1, respectively. The hESC line SA002 was recently reported to have an abnormal karyotype (trisomy 13), but within this population of cells we observed rare individual cells with an apparent normal karyotype. At a cloning efficiency of 5%, we established 33 subclones from SA002, out of which one had a diploid karyotype and this subline was designated SA002.5. From AS034.1 we established one reclone designated AS034.1.1 at a cloning efficiency of 0.1%. These two novel sublines express cell surface markers indicative of undifferentiated hESC (SSEA-3, SSEA-4, TRA-1-60, and TRA-1-81), Oct-4, alkaline phosphatase, and they display high telomerase activity. In addition, the cells are pluripotent and form derivatives of all three embryonic germ layers in vitro as well as in vivo. These results, together with the clonal character of SA002.5 and AS034.1.1 make these homogenous cell populations very useful for hESC based applications in drug development and toxicity testing. In addition, the combination of the parental trisomic hESC line SA002 and the diploid subclone SA002.5 provides a unique experimental system to study the molecular mechanisms underlying the pathologies associated with trisomy 13.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16324761     DOI: 10.1016/j.jbiotec.2005.10.010

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  10 in total

1.  A whole-mechanical method to establish human embryonic stem cell line HN4 from discarded embryos.

Authors:  Bin Li; Lan Xu; Wei-Ying Lu; Wen Xu; Mei-Hong Wang; Ke Yang; Juan Dong; Xiao-Yan Ding; Yuan-Hua Huang
Journal:  Cytotechnology       Date:  2010-10-26       Impact factor: 2.058

2.  Transcriptional expression profile of cultured human embryonic stem cells in vitro and in vivo.

Authors:  Marlen Keil; Antje Siegert; Klaus Eckert; Jörg Gerlach; Wolfram Haider; Iduna Fichtner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-02-04       Impact factor: 2.416

3.  Chemical enhancement in embryo development and stem cell derivation from single blastomeres.

Authors:  Chanchao Lorthongpanich; Shang-Hsun Yang; Karolina Piotrowska-Nitsche; Rangsun Parnpai; Anthony W S Chan
Journal:  Cloning Stem Cells       Date:  2008-12

4.  The establishment of 20 different human embryonic stem cell lines and subclones; a report on derivation, culture, characterisation and banking.

Authors:  Mikael C O Englund; Gunilla Caisander; Karin Noaksson; Katarina Emanuelsson; Kersti Lundin; Christina Bergh; Charles Hansson; Henrik Semb; Raimund Strehl; Johan Hyllner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2010-02-23       Impact factor: 2.416

5.  Human embryonic stem cells have a unique epigenetic signature.

Authors:  Marina Bibikova; Eugene Chudin; Bonnie Wu; Lixin Zhou; Eliza Wickham Garcia; Ying Liu; Soojung Shin; Todd W Plaia; Jonathan M Auerbach; Dan E Arking; Rodolfo Gonzalez; Jeremy Crook; Bruce Davidson; Thomas C Schulz; Allan Robins; Aparna Khanna; Peter Sartipy; Johan Hyllner; Padmavathy Vanguri; Smita Savant-Bhonsale; Alan K Smith; Aravinda Chakravarti; Anirban Maitra; Mahendra Rao; David L Barker; Jeanne F Loring; Jian-Bing Fan
Journal:  Genome Res       Date:  2006-08-09       Impact factor: 9.043

6.  Excess reactive oxygen species production mediates monoclonal antibody-induced human embryonic stem cell death via oncosis.

Authors:  Ji Yun Zheng; Heng Liang Tan; Paul Thomas Matsudaira; Andre Choo
Journal:  Cell Death Differ       Date:  2017-01-20       Impact factor: 15.828

7.  Efficacy of Human Embryonic Stem Cells Compared to Adipose Tissue-Derived Human Mesenchymal Stem/Stromal Cells for Repair of Murine Post-Stenotic Kidneys.

Authors:  Sarosh Siddiqi; Nattawat Klomjit; Kai Jiang; Sabena M Conley; Xianyang Zhu; Ishran M Saadiq; Christopher M Ferguson; Hui Tang; Amir Lerman; Lilach O Lerman
Journal:  Stem Cell Rev Rep       Date:  2022-09-01       Impact factor: 6.692

8.  Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity.

Authors:  Reha Yildirimman; Gabriella Brolén; Mireia Vilardell; Gustav Eriksson; Jane Synnergren; Hans Gmuender; Atanas Kamburov; Magnus Ingelman-Sundberg; José Castell; Agustin Lahoz; Jos Kleinjans; Joost van Delft; Petter Björquist; Ralf Herwig
Journal:  Toxicol Sci       Date:  2011-08-27       Impact factor: 4.849

Review 9.  The recent advances in the mathematical modelling of human pluripotent stem cells.

Authors:  L E Wadkin; S Orozco-Fuentes; I Neganova; M Lako; A Shukurov; N G Parker
Journal:  SN Appl Sci       Date:  2020-01-27

10.  Seeding hESCs to achieve optimal colony clonality.

Authors:  L E Wadkin; S Orozco-Fuentes; I Neganova; S Bojic; A Laude; M Lako; N G Parker; A Shukurov
Journal:  Sci Rep       Date:  2019-10-25       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.